Loop Capital upgraded shares of Enovix (NASDAQ:ENVX – Free Report) to a strong-buy rating in a report released on Monday,Zacks.com reports.
Other equities research analysts also recently issued research reports about the company. William Blair downgraded Enovix from an “outperform” rating to a “market perform” rating in a report on Monday. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. TD Cowen decreased their target price on shares of Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a report on Friday, July 24th. JPMorgan Chase & Co. lowered Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Finally, Oppenheimer lowered their price objective on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $11.77.
Check Out Our Latest Stock Analysis on ENVX
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The business had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same period in the previous year, the company earned ($0.13) earnings per share. The firm’s revenue for the quarter was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Analysts predict that Enovix will post -0.78 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Enovix
Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Enovix during the 2nd quarter valued at about $100,054,000. Vanguard Group Inc. raised its position in Enovix by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after acquiring an additional 1,747,145 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Enovix in the second quarter worth $8,689,000. Bank of America Corp DE purchased a new position in shares of Enovix in the second quarter worth about $8,356,000. Finally, Millennium Management LLC grew its position in shares of Enovix by 1,038.9% in the third quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after purchasing an additional 1,347,200 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.
Key Headlines Impacting Enovix
Here are the key news stories impacting Enovix this week:
- Positive Sentiment: Buy upgrade and improving estimates: Zacks upgraded Enovix to Rank #2 (Buy), citing growing optimism about the company’s earnings outlook. Separately, Zacks said ENVX is technically oversold after a steep four-week decline, while analysts have been revising earnings estimates higher—factors that could support a near-term rebound. Enovix upgraded to Buy Why Enovix’s trend might reverse
- Positive Sentiment: CEO transition described as strategic continuity: Enovix said the leadership change is a “CEO transition, not a strategy transition,” reaffirmed its third-quarter 2026 guidance, and reported approximately $552 million in cash. The sizable cash balance may ease near-term financing concerns and support continued development. Enovix CEO transition webcast
- Neutral Sentiment: Unusually high trading activity in Enovix call options indicates elevated speculative interest, but the report does not establish whether investors are positioning for a sustained rally or further volatility. Enovix call option activity
- Negative Sentiment: Analyst downgrade and recent low: William Blair cut ENVX to Market Perform, and the stock recently reached a new 12-month low after the downgrade. Reports also attributed the broader decline in battery-development stocks to sharply higher Treasury yields, which pressure speculative companies. William Blair downgrades Enovix Higher yields pressure speculative growth stocks
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Articles
- Five stocks we like better than Enovix
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
